American Association for Cancer Research

SHERPA: Unknown

People

  1. Patil
    Patil
  2. Feigin
    Feigin
  3. Traina
    Traina
  4. Hudis
    Hudis
  5. Comstock
    Comstock
  6. Gucalp
    Gucalp
  7. Norton
    Norton
  8. Akhtar
    Akhtar
  9. Geneus
    Geneus
  10. Giri
    Giri

Groups

  1. Breast Imaging Service (10)
  2. Radiology, Department of (10)
  3. Breast Medicine Service (7)
  4. Department of Medicine (7)
  5. Epidemiology and Biostatistics (7)
  6. Solid Tumor Oncology Division (7)
  7. Biostatistics Service (6)
  8. Body Imaging Service (6)
  9. Survivorship Research (6)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (4)
Search Within
  1. "Breast Imaging Service"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (2)
Groups
  1. Breast Imaging Service (10)
  2. Radiology, Department of (10)
  3. Breast Medicine Service (7)
  4. Department of Medicine (7)
  5. Epidemiology and Biostatistics (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Sujata Patil (6)
  2. Kimberly Feigin (5)
  3. Tiffany Traina (5)
  4. Clifford Hudis (4)
  5. Larry Norton (4)
  6. Ayca Gucalp (3)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (1)
  5. 2017 (1)
  6. 2013 (1)

More Years

Publications
  1. Cancer Research (8)
  2. Clinical Cancer Research (2)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A randomized phase 2 study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H.; Comen, E.; Bryce, Y.; Solomon, S. B.; Leal, J.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D.; Norton, L.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Utility of diffusion-weighted imaging to decrease unnecessary biopsies prompted by breast MRI: A trial of the ECOG-ACRIN Cancer Research Group (A6702)
    Journal Article

    Rahbar, H.; Zhang, Z.; Chenevert, T. L.; Romanoff, J.; Kitsch, A. E.; Hanna, L. G.; Harvey, S. M.; Moy, L.; DeMartini, W. B.; Dogan, B.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Edelweiss, M.; Patil, S.; Gounder, M. M.; Feigin, K. N.; Corben, A.; Arumov, A.; Traina, T. A.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Impact of magnetic resonance imaging on conversion from wide local excision to mastectomy in patients with ductal carcinoma in situ: First results from the ECOG-ACRIN 4112 prospective study
    Meeting Abstract

    Lehman, C. D.; Gatsonis, C.; Greco, E.; Khan, S. A.; Sparano, J. A.; Solin, L. J.; Badve, S. S.; Corsetti, R. L.; Rahbar, H.; Spell, D. W.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)
    Meeting Abstract

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • ACOSOG Z11101/ACRIN 6694: Effect of preoperative breast MRI on surgical outcomes, costs and quality of life of women with breast cancer
    Meeting Abstract

    Bedrosian, I.; Suman, V. J.; Yao, K.; Shih, Y. C. T.; Yen, T. W. F.; Comstock, C.; Newstead, G.; Birdwell, R.; Kim, E.; L'Heureux, D. Z.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Gajria, D.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; Hudis, C.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: